Related Experiment Video
Updated: Feb 13, 2026
08:40
Rat Burn Model to Study Full-Thickness Cutaneous Thermal Burn and Infection
Published on: August 23, 2022
6.2K
Post burn pruritus in pediatric burn patients
Sophie Maria Pierrette Nieuwendijk1, Iris Johanne de Korte1, Mereille Marren Pursad2
1Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands; Department of Pediatric Surgery, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
Summary
Post-burn pruritus affects over 70% of pediatric patients, with deeper wounds and larger burn areas increasing severity. Current treatments offer limited relief, highlighting a need for better pediatric burn care strategies.
Area of Science:
- Pediatric Burn Care
- Dermatology
- Wound Healing
Background:
- Pruritus (itching) is a common and distressing symptom following burn wound healing.
- Limited research exists on pediatric burn pruritus, necessitating specific investigation in this age group.
Purpose of the Study:
- To determine the incidence and severity of pruritus in pediatric burn patients.
- To identify predictors associated with post-burn pruritus in children.
- To evaluate the effectiveness of pharmacological treatments for pediatric burn pruritus.
Main Methods:
- Prospective observational study design.
- Utilized numeric rating scale and Itch Man Scale for pruritus assessment.
- Employed Fisher exact and Kruskal-Wallis tests for predictor analysis.
Main Results:
- Pruritus was reported in 71.7% of 413 pediatric patients.
- Significant predictors included time since burn, injury depth, Total Surface Area (TBSA) burned, and skin grafting.
- Only 29.8% of patients using medication achieved complete symptom relief.
Conclusions:
- Post-burn pruritus remains highly prevalent in pediatric burn care.
- Pruritus intensity and frequency are exacerbated by deeper wounds, larger TBSA, and occur more frequently within the first three months post-burn.
More Related Videos
Related Concept Videos
01:22Burn Injuries
4.6K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.6K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
277
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
246
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
246
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
310
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
310
01:27Post-traumatic Stress Disorder
590
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
590